Eosinophil Markers and Development of Disease in Allergic Rhinitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01192386|
Recruitment Status : Completed
First Posted : September 1, 2010
Last Update Posted : September 1, 2010
|Condition or disease|
|Seasonal Allergic Rhinitis|
The study consists of a single visit at which patients fill in a questionnaire on actual hayfever and asthma symptoms as well as current treatment. Blood samples and nasal lavages are drawn and analysed for eosinophils as well as eosinophil cationic protein and tryptase. Spirometry is performed.
If patients use drugs which can interfere with results, ie. corticosteroids or beta-agonists, biochemistry and/or spirometry are omitted.
|Study Type :||Observational|
|Actual Enrollment :||29 participants|
|Official Title:||Eosinophil Markers and Development of Disease in Allergic Rhinitis. A 15-year Follow-up of Patients With Grass Pollen Induced Hayfever.|
|Study Start Date :||May 2010|
|Actual Primary Completion Date :||May 2010|
|Actual Study Completion Date :||May 2010|
- Asthma morbidity [ Time Frame: Single measurement - May 2010 ]Patients are asked whether they have experienced asthmatic symptoms or have been disgnosed with asthma within the latest 15 years
- Rhinitis morbidity [ Time Frame: Single measurement - May 2010 ]Patients are asked for current hayfever symptoms
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01192386
|Principal Investigator:||Lars Peter Nielsen, MD||Department of Respiratory Research, Aarhus University Hospital, DK-8000 Aarhus C, Denmark|